Page last updated: 2024-11-02

phenylbutazone and Acute Myelogenous Leukemia

phenylbutazone has been researched along with Acute Myelogenous Leukemia in 2 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hinterberger, W1
Kinast, H1
Tragl, KH1
Hamer, JW1
Gunz, FW1

Other Studies

2 other studies available for phenylbutazone and Acute Myelogenous Leukemia

ArticleYear
[Anaemia with medullary myeloblastosis (author's transl)].
    Wiener klinische Wochenschrift, 1977, Dec-23, Volume: 89, Issue:24

    Topics: Aged; Aminopyrine; Anemia, Aplastic; Arthritis, Rheumatoid; Bone Marrow Examination; Drug Combinatio

1977
Multiple aetiological factors in a case of acute leukaemia.
    The New Zealand medical journal, 1970, Volume: 71, Issue:454

    Topics: Acute Disease; Aged; Bone Marrow; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male

1970